http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Owner of Arkansas Derby Winner Named Horse After the Life-Changing Accuray CyberKnife® Radiation Therapy Technology Used to Treat His Cancer
-
Accuray to Report Third Quarter Fiscal 2022 Financial Results on April 27, 2022
-
Accuray (ARAY) 10-Year Data Shows Accuray CyberKnife System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia
-
10-Year Data Shows Accuray CyberKnife® System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia
-
Accuray's (ARAY) Accuray CyberKnife S7 Selected by CARTI to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas
-
CARTI Selects Accuray CyberKnife® S7™ System to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas
-
NICE Endorses Radiosurgery Treatments for Trigeminal Neuralgia, Supporting Accuray CyberKnife® System Indications for Use
-
Accuray (ARAY) Announces Largest Hospital in Queensland, Australia Acquires Multiple Radixact Systems
-
Largest Hospital in Queensland, Australia Acquires Multiple Accuray Radixact® Systems with the ClearRT™ Helical Fan-Beam kVCT Imaging and Synchrony® Technologies
-
Accuray TomoTherapy® Helical Radiotherapy System Helps Preserve Breast Cancer Patients' Long-term Heart and Lung Functionality
-
Accuray to Report Second Quarter Fiscal 2022 Financial Results on January 26, 2022
-
Accuray (ARAY) CyberKnife Receives Shonin Approval to Treat Trigeminal Neuralgia
-
Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve
-
Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively Treated With Stereotactic Radiosurgery
-
Accuray To Participate at Stifel 2021 Virtual Healthcare Conference
-
Study Shows Accuray's (ARAY) CyberKnife Could Significantly Improve Survival in Early-Stage Breast Cancer Patients
-
Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer Patients
-
Accuray Unveils VOLO™ Ultra, the Latest Innovation for the Radixact® System, at ASTRO 2021
-
Accuray to Report First Quarter Fiscal 2022 Financial Results on November 3, 2021
-
Accuray to Host ASTRO Analyst & Investor Meeting on October 25, 2021
-
C-RAD and Accuray Sign Agreement to Enhance Radixact® System Breast Cancer Treatment Capabilities
-
French Hospital Network Unicancer Acquires Multiple Accuray Radixact® Systems with the ClearRT™ Helical Fan-Beam kVCT Imaging and Synchrony® Technologies
-
Nagoya City University Hospital is First in Japan to Treat Cancer Patients Using the Accuray Radixact® System with ClearRT™ Helical Fan-Beam kVCT Imaging
-
Accuray CyberKnife® Robotic Radiotherapy Platform is Superior to Conventional Linear Accelerators in Reducing Incidence of Bladder Side Effects in Prostate Cancer Patients
-
Accuray (ARAY) Appoints Mika Nishimura to its Board
-
Mika Nishimura Joins Accuray Board of Directors
-
Hong Kong Sanatorium & Hospital Transforms Cancer Care in Asia with Treatment of First Patient Using the Accuray Radixact® System and ClearRT™ Helical Fan-Beam kVCT Imaging
-
Accuray to Report Fiscal Year-End 2021 Financial Results on August 11, 2021
-
Beloved Family Pet's Lung Cancer is Treated with Targeted Radiotherapy Using the Accuray Radixact® System with Synchrony® Technology
-
Accuray (ARAY) Announces Promotion of Suzanne Winter to President
-
Accuray Announces Promotion of Suzanne Winter to President
-
Accuray Expands CyberKnife® System Versatility with Integration of RaySearch's RayStation Treatment Planning System
-
Accuray Expands Commercialization of ClearRT™ Helical Fan-Beam kVCT Imaging for the Radixact® System with CE Mark Certification
-
Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
-
Geisinger becomes first in U.S. to treat cancer patients with Accuray Synchrony® technology on the Radixact® and CyberKnife® S7™ Systems to better target radiation treatments
-
Accuray Customers Achieve Top Scores in AAPM MArkerless Lung Target Tracking CHallenge (MATCH) Using Synchrony® Technology on the Radixact® and CyberKnife® Systems
-
Accuray Appoints Jean-Philippe Pignol, M.D., Ph.D. as Chief Medical & Technology Officer
-
Accuray (ARAY) Receives Shonin Approval for ClearRT Helical kVCT Imaging, CE Mark Expected by End of June; Expands Commercial Launch
-
Accuray Receives Shonin Approval for ClearRT™ Helical kVCT Imaging, CE Mark Expected by End of June; Expands Commercial Launch
-
Accuray to Report Third Quarter Fiscal 2021 Financial Results on April 27, 2021
-
Accuray to Participate in the Cowen 41st Annual Health Care Conference
-
Accuray Appoints Healthcare Executive and Physician Byron C. Scott to Board of Directors
-
Accuray to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
-
Accuray (ARAY) Announces Seven-year Data Shows System Provides Excellent Long-Term Control of Low-Risk Breast Cancer
-
Seven-year Data Shows Accuray TomoTherapy® System Provides Excellent Long-Term Control of Low-Risk Breast Cancer
-
Accuray to Report Second Quarter Fiscal 2021 Financial Results on January 27, 2021
-
Accuray To Participate at J.P. Morgan's 39th Annual Healthcare Conference
-
Accuray (ARAY) Receives 510(k) FDA Clearance for ClearRT Helical kVCT Imaging for the Radixact Treatment Delivery System
-
Accuray Receives 510(k) FDA Clearance for ClearRT™ Helical kVCT Imaging for the Radixact® Treatment Delivery System
-
Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules

